Navigation Links
Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims

Parker Waichman Alonso LLP Announces Opening of Dedicated Claims Center To Evaluate Numerous Possible Lawsuits Related to Defective Sprint Fidelis

Leads Used With Medtronic Implantable Defibrillators

NEW YORK, Oct. 24 /PRNewswire/ -- The defective Medtronic Sprint Fidelis Defibrillator Leads were implanted into hundreds of thousands of people, leaving all of them at risk for serious injury if a Sprint Fidelis Lead fractures. As a result of this, Parker Waichman Alonso LLP has opened a dedicated Claims Center within their office to review the potential lawsuits of people who were implanted with defective Sprint Fidelis Leads used with Medtronic defibrillators. Medtronic suspended sales and recalled all unused Sprint Fidelis Leads on October 15, 2007 after receiving reports of at least 5 fatalities linked to lead fractures. Parker Waichman Alonso LLP recently filed a lawsuit on behalf of a man who had to undergo a dangerous and life- threatening surgical procedure after a Sprint Fidelis Lead fractured. Parker Waichman Alonso LLP is seeking class action status for this lawsuit to represent all persons in the United States who were implanted with defective leads manufactured by Medtronic, Inc.

If you or a loved one received a Sprint Fidelis Lead with a Medtronic implantable defibrillator, please contact our claims center by visiting Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

The Sprint Fidelis Lead is a wire that is used to attach a Medtronic implantable defibrillator to the heart. The Sprint Fidelis Lead was first introduced by Medtronic in 2004, and has been used with most of the company's implantable defibrillators since then. This component is used in cardiac defibrillators -- or complex devices with defibrillation capacity -- and not in conventional pacemakers. Some patients with congestive heart failure use devices that include this defibrillation ability, and those are among the machines that use the Sprint Fidelis Lead.

Medtronic's Sprint Fidelis Leads have been shown to have a continuing fracture problem. This defect can cause the defibrillators to deliver a massive and painful electrical shock, or it can cause the device to fail to administer a lifesaving shock when necessary. Such defects were discussed in an article written by doctors at The Minneapolis Heart Institute, one of the premier heart institutes in the world. The researchers at the Minneapolis Heart Institute compared data regarding lead failures in both the Sprint Fidelis models and Medtronic's earlier Sprint Quattro models. The study found the thinner Sprint Fidelis Lead had a higher chance of fracturing than the Sprint Quattro. According to Medtronic's own estimate, approximately 2.3%, or 4,000 to 5,000 people with a Sprint Fidelis Lead will experience fracture within 30 months of having a defibrillator implanted.

When a Sprint Fidelis Lead fractures, a patient must undergo a surgical procedure that can tear and scar the heart tissue and veins through which the Sprint Fidelis Lead wire runs. The surgery to replace a defibrillator lead wire is far riskier than having the device itself replaced.

About Parker Waichman Alonso LLP:

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, drugs and medical devices.

For more information on Parker Waichman Alonso LLP, please visit: or call 1-800-LAW-INFO (1-800-529-4636).

CONTACT: Parker Waichman Alonso LLP

David Krangle, Esq.

(800) LAW-INFO

(800) 529-4636

SOURCE Parker Waichman Alonso LLP
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medtronic’s Insulin Pump Receives Regulatory Approva
2. Medtronic Device Proves Effective in Parkinson’s Diseas
3. Short Sprint to Aid in Blood Sugar Recovery among Type 1 Diabetes
4. Defibrillators In Public Places Will Help Cardiac Patients
5. Need to use defibrillators
6. Defibrillators saving lives but price is an issue
7. Public Defibrillators Found To Improve Survival Rate
8. Guidant sold defective defibrillators with full knowledge
9. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
10. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
11. New Test Identifies Candidates For Cardiac Defibrillator
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer Dr. ... colleagues, skilled nursing facility medical directors and other clinicians at various events in ... , "At many of these conferences we get to educate other physicians, facility ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: